Cargando…
Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
Autores principales: | Abuabara, K., Nicholls, S.G., Langan, S.M., Guttman‐Yassky, E., Reynolds, N.J., Paller, A.S., Brown, S.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359998/ https://www.ncbi.nlm.nih.gov/pubmed/33570761 http://dx.doi.org/10.1111/bjd.19874 |
Ejemplares similares
-
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement
por: Drucker, A.M., et al.
Publicado: (2018) -
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019) -
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019) -
Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council
por: Eyerich, Kilian, et al.
Publicado: (2018) -
Identifying priority questions regarding rapid systematic reviews’ methods: protocol for an eDelphi study
por: Vieira, Ariany M, et al.
Publicado: (2023)